Texas Oncology Overview
Printer Friendly PDF
Texas Oncology physicians bring the power and resources of a world-class network to bear for patients fighting cancer. They use the latest in pharmaceuticals and leading-edge technologies, and conduct clinical research. More than 80 percent of all cancer care is provided in an out-patient setting. As a pioneer in community-based cancer care, Texas Oncology’s approach enables patients to receive industry-leading treatment without leaving home and the critical support of family and friends.
Founded in 1986, Texas Oncology’s more than 375 physicians are strong patient advocates and provide treatment and care at 150 sites of service throughout Texas and southeastern Oklahoma.
Specialty areas include “related” practices such as urology and breast care specialties. A national leader in cancer risk assessment, the Genetic Risk Evaluation And Testing Programprovides an in-depth assessment for individuals with a strong personal and/or family history of cancer and can help identify patients at risk for hereditary cancer syndromes.
Throughout the Texas Oncology network, physicians have the opportunity to collaborate and share best practices with each other, so that each physician can stay focused on what they do best – caring for patients.
Patients have access to leading-edge technologies and treatments, including:
- Computed tomography (CT)
- Contura Balloon
- Elekta Volumetric Modulated Arc Therapy (VMAT)
- External portal imaging device/computerized radiography
- High dose rate (HDR) brachytherapy
- Intensity modulated radiation therapy (IMRT)
- Low dose rate (LDR) brachytherapy radioactive seed implants
- Novalis Tx™
- On-Board Imager® (OBI) with Cone Beam Computed Tomography (CBCT)
- Positron emission technology (PET)
- Virtual CT simulator
These tools and treatments allow physicians to create highly personalized treatment plans for each patient, targeting cancerous tumors while preserving surrounding tissue. Advanced technologies can mean shorter treatment times and fewer side effects for patients.
Texas Oncology has been instrumental in bringing new treatment advances to the marketplace. Patients have the option to participate in some of the most promising national clinical trials for a broad range of cancers.
- Texas Oncology has played a critical role in gaining Food and Drug Administration (FDA) approval for 46 cancer-fighting
- Texas Oncology physicians are regularly selected to present their research at major medical conferences.
- Last year, more than 1,500 Texas Oncology patients participated in clinical trials.
- Patients had access to more than 40 clinical trials for all types of cancers, including lung cancer, colon cancer, and breast cancers.